We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CKPT market cap is 152.85M. The company's latest EPS is USD -1.0617 and P/E is -2.96.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31k | 6k | 0 | 41k | 0 |
| Operating Income | -7.7M | -10.17M | -10.95M | -6.67M | -9.72M |
| Net Income | -5.72M | -19.13M | -10.95M | -6.67M | -9.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.71M | 1.07M | 268k | 192k | 103k |
| Operating Income | -24.85M | -23.2M | -56.72M | -58.33M | -52.15M |
| Net Income | -24.71M | -23.08M | -56.67M | -62.62M | -51.85M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.22M | 5.38M | 11.98M | 5.67M | 5.18M |
| Total Liabilities | 21.26M | 18.43M | 22.23M | 21.42M | 17.77M |
| Total Equity | -19.04M | -13.05M | -10.25M | -15.75M | -12.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.97M | 42.6M | 55.73M | 13.29M | 5.38M |
| Total Liabilities | 8.12M | 7.22M | 25.98M | 32.77M | 18.43M |
| Total Equity | 18.85M | 35.38M | 29.75M | -19.48M | -13.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.76M | -47.59M | -6.47M | -12.71M | -23.92M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 30.46M | 40.45M | 12.79M | 12.74M | 23.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.37M | -16.55M | -26.31M | -57.55M | -47.59M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 25.46M | 31.25M | 40.27M | 14.89M | 40.45M |
| Market Cap | 152.85M |
| Price to Earnings Ratio | -2.96 |
| Price to Sales Ratio | 1.5k |
| Price to Cash Ratio | 31.12 |
| Price to Book Ratio | -11.75 |
| Dividend Yield | - |
| Shares Outstanding | 48.83M |
| Average Volume (1 week) | 834.43k |
| Average Volume (1 Month) | 874.16k |
| 52 Week Change | 54.19% |
| 52 Week High | 4.50 |
| 52 Week Low | 1.38 |
| Spread (Intraday) | 0.07 (2.19%) |
| Company Name | Checkpoint Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.checkpointtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
